Diabetic Nephropathy News and Research

RSS
Diabetic nephropathy is kidney disease or damage that results as a complication of diabetes.
Diabetic Neuropathy: An interview with Dr Brian Callaghan

Diabetic Neuropathy: An interview with Dr Brian Callaghan

Bariatric surgery can remit or prevent diabetic nephropathy in obese patients

Bariatric surgery can remit or prevent diabetic nephropathy in obese patients

ChemoCentryx fourth quarter revenues increase to $26.1 million

ChemoCentryx fourth quarter revenues increase to $26.1 million

Concert commences dosing in CTP-499 Phase 2 clinical trial for diabetic nephropathy

Concert commences dosing in CTP-499 Phase 2 clinical trial for diabetic nephropathy

Questcor fourth quarter net sales increase to $75.5 million

Questcor fourth quarter net sales increase to $75.5 million

New biomarkers can predict risk of kidney failure in patients with diabetes

New biomarkers can predict risk of kidney failure in patients with diabetes

Questcor reports record vial shipments of Acthar in fourth quarter 2011

Questcor reports record vial shipments of Acthar in fourth quarter 2011

GSK obtains exclusive license to ChemoCentryx's CCX354 CCR1 inhibitor for RA

GSK obtains exclusive license to ChemoCentryx's CCX354 CCR1 inhibitor for RA

JAMA commentary argues that vitamin therapy still plays a role in reducing stroke

JAMA commentary argues that vitamin therapy still plays a role in reducing stroke

ChemoCentryx commences CCX140 Phase II trial in diabetic nephropathy

ChemoCentryx commences CCX140 Phase II trial in diabetic nephropathy

Concert to initiate CTP-499 Phase 2 diabetic nephropathy clinical trial in 2012

Concert to initiate CTP-499 Phase 2 diabetic nephropathy clinical trial in 2012

Positive results from ChemoCentryx CCX354 Phase II study on RA

Positive results from ChemoCentryx CCX354 Phase II study on RA

Arginase-2 enzyme plays a major role in diabetic nephropathy

Arginase-2 enzyme plays a major role in diabetic nephropathy

JDC receives NIDDK grant for research into diabetic retinopathy, kidney disease

JDC receives NIDDK grant for research into diabetic retinopathy, kidney disease

Sulodexide drug fails to benefit diabetes patients with kidney disease

Sulodexide drug fails to benefit diabetes patients with kidney disease

Data from Concert Pharmaceuticals' CTP-499 study to be presented at ASN Kidney Week 2011

Data from Concert Pharmaceuticals' CTP-499 study to be presented at ASN Kidney Week 2011

ChemoCentryx commences CCX168 Phase II trial in ANCA-associated vasculitis

ChemoCentryx commences CCX168 Phase II trial in ANCA-associated vasculitis

UC San Diego professor receives NIDDK grant to study kidney complications related to diabetes

UC San Diego professor receives NIDDK grant to study kidney complications related to diabetes

Lack of kidney dopamine leads to high blood pressure and shorter life span

Lack of kidney dopamine leads to high blood pressure and shorter life span

ASN President discusses latest information about diabetic nephropathy at ADA

ASN President discusses latest information about diabetic nephropathy at ADA